Brooklyn Investment Group’s CRISPR Therapeutics CRSP Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q2	$10.9K	Buy	224 +165	+280%	+$8.03K	﹤0.01%	2133
2025 Q1	$2.01K	Buy	+59	New	+$2.01K	﹤0.01%	2160